Home › Cases › Delirium Tremens
Alcohol Withdrawal
Delirium Tremens
6 questions
Question 1 · Delirium tremens
Correct answer: Delirium tremens (DTs) — severe alcohol withdrawal, typically 48-72h after last drink
Why
Delirium tremens: severe alcohol withdrawal — onset 48-72h after last drink. Features: severe agitation, confusion, hallucinations (visual, tactile), autonomic instability (tachycardia, hypertension, sweating, fever), seizures. CIWA-Ar is unreliable in delirium; monitor with RASS and clinical observations. Mortality 5-15% if untreated.
Key point
Delirium tremens: 48-72h after last drink. Hallucinations + autonomic instability. 5-15% mortality if untreated.
Question 2 · DTs treatment
Correct answer: IV diazepam or lorazepam titrated to calm/light sedation, with frequent observations and RASS. High-dose benzodiazepines required — ICU for refractory symptoms; propofol only if mechanically ventilated
Why
DTs treatment: IV benzodiazepine titrated to calm/light sedation (IV diazepam 5-10mg every 15-30min until controlled, or front-loading protocol). Use RASS with frequent clinical observations, not CIWA-Ar. Refractory DTs: ICU; phenobarbital may be added under close monitoring. Propofol only if already mechanically ventilated; dexmedetomidine is an ICU adjunct. Always: IV thiamine, IV fluids, electrolytes (hypokalaemia, hypomagnesaemia common).
Key point
DTs: IV benzodiazepines to calm/light sedation, with RASS and clinical observations. High doses may be needed; ICU if refractory.
Question 3 · Monitoring
Correct answer: Respiratory depression from high-dose benzodiazepines. Monitor RR, SpO2. Support airway/ventilation and call anaesthetics if respiratory depression develops. May need ICU and intubation
Why
BDZ monitoring in DTs: respiratory depression is the main risk, especially with IV diazepam (long-acting). Monitor RR and SpO2 continuously. If respiratory depression develops, support airway/ventilation and call anaesthetics. Flumazenil is not routine rescue here: withdrawal and seizures are risks; seek specialist advice. ICU if massive doses required or respiratory compromise. Pulse oximetry, ECG monitoring.
Key point
BDZ in DTs: monitor RR and SpO2 for respiratory depression. Respiratory depression: airway support and anaesthetics. ICU if high doses or respiratory compromise.
Question 4 · Electrolytes in DTs
Correct answer: Hypokalaemia, hypomagnesaemia, hypophosphataemia common — all lower seizure threshold and worsen arrhythmia risk in DTs
Why
Electrolytes in DTs: alcohol causes magnesium wasting (hypomagnesaemia lowers seizure threshold and causes refractory hypokalaemia). Hypokalaemia (vomiting, diuresis). Hypophosphataemia (refeeding risk). All increase seizure and arrhythmia risk. Correct aggressively: IV magnesium sulphate 4-8 mmol, KCl replacement.
Key point
DTs: correct hypomagnesaemia, hypokalaemia, hypophosphataemia. All lower seizure threshold and worsen arrhythmia.
Question 5 · Anticonvulsants
Correct answer: Benzodiazepines are first-line; do not use phenytoin for alcohol withdrawal seizures
Why
Benzodiazepines are first-line for seizure prevention and treatment in this patient with DTs. Phenytoin does not treat alcohol withdrawal seizures. Carbamazepine can be an alternative for selected mild–moderate withdrawal when benzodiazepines are unsuitable; it is not a substitute for benzodiazepines in DTs. Continue usual anticonvulsants for pre-existing epilepsy.
Key point
DTs: benzodiazepines first-line. Do not use phenytoin for withdrawal seizures; carbamazepine has a separate role in selected uncomplicated withdrawal.
Question 6 · Post-DTs management
Correct answer: Alcohol liaison nurse/psychiatry referral. Acamprosate or naltrexone (anti-craving). Peer support (AA). Hepatology if liver disease. Address social needs
Why
Post-DTs discharge planning: alcohol liaison referral, community alcohol support, AA and social support. With psychosocial treatment, consider acamprosate 666mg TDS if ≥60kg (below 60kg: 666mg morning, 333mg afternoon and evening) or naltrexone 25mg initially, then 50mg OD. Check renal/liver function and contraindications; exclude opioid use before naltrexone. Disulfiram is an alternative for a motivated patient after safety checks, including LFTs and interactions; avoid alcohol during treatment and for 14 days afterwards. No driving; notify DVLA because of alcohol dependence. Disulfiram can also cause drowsiness.
Key point
Post-DTs: alcohol liaison referral, acamprosate or naltrexone for craving, social support. Disulfiram only if motivated and safe.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.